PABLO
ROJO CONEJO
Profesor titular de universidad
David Geffen School of Medicine at UCLA
Los Ángeles, Estados UnidosPublicacions en col·laboració amb investigadors/es de David Geffen School of Medicine at UCLA (7)
2024
-
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial
Clinical Infectious Diseases, Vol. 78, Núm. 3, pp. 702-710
2023
-
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium
PLoS ONE, Vol. 18, Núm. 1 January
-
Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change
Journal of Acquired Immune Deficiency Syndromes, Vol. 93, Núm. 1, pp. 42-46
-
First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia
Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 11, pp. 581-585
-
Potential pitfalls in the use of real-world data for studying long COVID
Nature Medicine
2022
-
Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial
Trials, Vol. 23, Núm. 1
-
International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality
npj Digital Medicine, Vol. 5, Núm. 1